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Abstract Identification of predictors of cardiovascular risk
can help in the prevention of pathologic episodes and the
management of patients at all stages of illness. Here, we
investigated the relationships between serum levels of
Hsp60 and dyslipidemia in patients with periodontitis by
performing a cross-sectional study of 22 patients with mild
periodontitis without any prior treatment for it (i.e., drug
naïve) and 22 healthy controls, matched for age and body
mass index (BMI). All subjects were evaluated for peri-
odontal status, gingival inflammation, and oral hygiene.
Levels of circulating Hsp60, C-reactive protein (CRP), and
plasma lipids were measured, and small, dense low-density
lipoproteins (LDL) were indirectly assessed by determining
the triglycerides/high-density lipoproteins (HDL) cholesterol
ratio. We also assessed by immunohistochemistry Hsp60
levels in oral mucosa of patients and controls. No
difference was found in CRP levels or plasma lipids
between the two groups, but subjects with periodontitis
showed, in comparison to controls, higher levels of
small, dense LDL (p00.0355) and circulating Hsp60
concentrations (p<0.0001). However, levels of mucosal
Hsp60 did not change significantly between groups.
Correlation analysis revealed that circulating Hsp60 inversely
correlated with HDL-cholesterol (r0−0.589, p00.0039), and
positively with triglycerides (r0+0.877, p<0.0001), and
small, dense LDL (r0+0.925, p<0.0001). Serum Hsp60 sig-
nificantly correlated with the degree of periodontal dis-
ease (r0+0.403, p00.0434). In brief, untreated patients
with mild periodontitis had increased small, dense LDL
and serum Hsp60 concentrations, in comparison to age- and
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BMI-matched controls and both parameters showed a strong
positive correlation. Our data indicate that atherogenic dysli-
pidemia and elevated circulating Hsp60 tend to be linked and
associated to periodontal pathology. Thus, the road is open to
investigate the potential value of elevated levels of circulating
Hsp60 as predictor of risk for cardiovascular disease when
associated to dyslipidemia in periodontitis patients.
Keywords Periodontitis . Hsp60 . Small, dense LDL . Risk
factors . Cardiovascular disease
Introduction
Periodontitis is a chronic infectious disease commonly affect-
ing adults, characterized by a progressive gingival inflamma-
tory response to bacteria in dental plaques (Williams 1990).
Evidence suggests that the local inflammation-infection trig-
gers a systemic host response that is paralleled by an increased
risk for cardiovascular diseases (Scannapieco et al. 2003).
Periodontitis has also been associatedwith glucose intolerance
(Saito et al. 2004), procoagulant condition (Taylor et al. 2006),
endothelial dysfunction (Tonetti et al. 2007), and dyslipidemia
and metabolic syndrome (D’Aiuto et al. 2008). It has recently
been suggested that the heat-shock protein (Hsp) 60 kDa
(Hsp60) might be the link between periodontitis and athero-
sclerosis (Choi et al. 2011). Hsps are produced in response to
stress induced by a variety of stressors that disturb cellular
homeostasis and, under physiological conditions, Hsps assist
newly formed or partially denatured proteins to either fold
correctly or refold, respectively (references in Macario and
Conway de Macario 2005). Although Hsps were first identi-
fied as intracellular proteins, further studies showed that they
are actively secreted by cells reaching the bloodstream, by
which they interact with the immune system (references in
Pockley and Multhoff 2008; Pockley et al. 2008; Macario et
al. 2010). It has been known for over 10 years that Hsp60 can
be found in the peripheral circulation (Pockley et al. 1999), but
only recently it has been shown that Hsp60 can be secreted,
via various pathways, from normal and tumor human cells
(Gupta and Knowlton 2007; Merendino et al. 2010; reviewed
in De Maio 2011).
Data from various reports show an elevated humoral
immune response to Hsp60 (both human and bacterial) in
patients with periodontitis (Tabeta et al. 2000; Yamazaki et
al. 2002; Yamazaki et al. 2004; Choi et al. 2004; Buhlin et
al. 2009). This supports the view that molecular mimicry
between bacterial and human Hsp60 may play a role in
immune mechanisms triggered by antigenic cross-reaction
(Cappello et al. 2009; Linhares and Witkin 2010). Hsp60
has been detected on the membrane surface of stressed
human endothelial cells, in which it may become an auto-
antigen for anti-Hsp60 antibodies (Pfister et al. 2005), in
agreement with recent work suggesting that Hsp60 is asso-
ciated with atherosclerosis development and progression
(Pockley et al. 2000; Knoflach et al. 2005; Zhang et al.
2008; Novo et al. 2011).
Along these lines, we investigated relationships between
levels of circulating human Hsp60 and risk factors for
cardiovascular diseases, particularly atherogenic dyslipide-
mia, in patients with periodontitis. We studied subjects with
mild periodontitis but without any prior treatment for it (i.e.,
drug naïve), compared to healthy controls matched for age
and body mass index (BMI). Although finding parallelism
between certain clinical and pathological observations does
not establish cause-effect relationships, it provides indicators
with potential diagnostic and prognostic usefulness. For
example, levels of Hsp60 in tissues and in circulation
have been found elevated or decreased in relation to
pathologic parameters, and the consistency of the find-
ings encourages the measurement of the chaperone with
diagnostic purposes and to assess prognosis and response to
treatment. The main goal of the work presented here was to
determine if the serum levels of Hsp60 paralleled dyslipide-
mia in subjects with periodontal inflammation-infection and
could serve as another indicator of risk for cardiovascular
disease.
Materials and methods
Subjects and study protocol
Twenty-two patients with untreated mild periodontitis were
studied. The patients were admitted consecutively in the
Periodontology Department, University of Granada, Spain.
At admission all subjects underwent a medical examination,
including a blood test, and also answered a questionnaire on
personal and medical items, including age, past medical
history, and use of medications. The adopted procedures
were in agreement with the Helsinki Declaration of 1975,
as revised in 1983. The study was approved by the Ethics
Committee of the University of Granada, Spain, and each
subject gave written informed consent to participate in this
study. Inclusion criteria were adult age, presence of peri-
odontal disease as diagnosed according to the criteria of
Arbes et al. (1999), presence of at least five teeth in the
mouth, and consent to participate in the study. Exclusion
criteria were: previous cardiovascular disease; occurrence of
any inflammatory condition other than periodontitis; pres-
ence of renal, hepatic, or thyroid disease; use of beta block-
ers, hypolipidemia-inducing drugs, or any other modifier of
plasma lipids and lipoproteins.
Twenty-two healthy subjects matched for age and
BMI were included as controls, with the same exclusion
criteria as described above, who were co-workers or
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family co-workers. Height and weight were recorded
and BMI was calculated as kg⁄m2. The cardiovascular
risk factors taken into consideration were: hypertension
(systolic or diastolic blood pressure, respectively, ≥140
or ≥90 mmHg or previous pharmacological therapy with
antihypertensive drugs), diabetes (fasting glucose plasma
concentrations higher than 126 mg⁄dl or previous phar-
macological therapy with antidiabetic drugs or insulin),
and smoking addiction.
Periodontal examination
The oral examination was performed by a single dentist
(RM) at the Periodontology Department of the University
of Granada, Spain. The diagnosis of periodontitis was com-
pared with that of another dentist (FM) in 13 patients,
obtaining intraclass correlation coefficients (for gingival
recession and pocket depth) above 0.71, which is considered
substantial according to the scale of Landis and Koch
(1977). The loss of periodontal attachment was measured
using the PCPUNC-15 periodontal probe (Hu-Friedy,
Leimen, Germany) and a number 5 non-magnifying oral
mirror (SE plus) by adding the pocket depths and gingival
recessions (in millimeters). Six sites per tooth (mesiobuccal,
buccal, distobuccal, mesiolingual, lingual, and distolingual)
were examined for all the teeth present in the oral cavity.
The degree of periodontal disease was defined, as we pre-
viously reported (Cueto et al. 2005), by the percentage
of sites with loss of attachment ≥3 mm as follows: 0% 0
absent, 0–32% 0 mild, 33–66% 0 moderate, and 67–
100% 0 severe, according to the criteria of Arbes et al.
(1999). The gingival bleeding index of Ainamo and Bay
(1975) and the plaque index of O'Leary et al. (1972)
were also determined in order to assess the degree of
gingival inflammation and oral hygiene, respectively.
All patients had mild periodontitis.
Laboratory analyses
Whole blood was collected from each subject, after 12–
14-h overnight fast, in sodium-EDTA tubes and stored at
−80°C until analysis. Total cholesterol, triglycerides, and
high-density lipoproteins (HDL)-cholesterol were quantified
by standard enzymatic-colorimetric methods (Allain et al.
1974; Nagele et al. 1984; Warnick et al. 1985). Low-density
lipoproteins (LDL)-cholesterol was calculated using the
Friedewald formula. Non-HDL-cholesterol was calculated as
total cholesterol minus HDL-cholesterol. The triglycerides/
HDL-cholesterol ratio was calculated as an indirect measure
of small, dense LDL particles (Décary et al. 2010). C-reactive
protein (CRP) was determined by the nephelometric method
(Montagne et al. 1992).
Hsp60 determination in patients’ sera by ELISA
A blood sample from each subject was allowed to clot at
room temperature for 30 minutes. After a centrifugation at
2,700×g for 10 min, sera were collected, aliquoted and
stored at −20°C until use. The levels of human circulating
Hsp60 in sera were determined by Hsp60 (human) enzyme
immunoassay (EIA) quantitative sandwich immunoassay
(ADI EKS 600 ELISA kit, Stressgen). A mouse monoclonal
antibody specific for Hsp60 is pre-coated on the wells of the
Hsp60 Immunoassay Plate. All reagents were brought to 24°C
and the Hsp60 standard was diluted in sample diluent to
generate a standard curve with six points, ranging from
3.125 to 100 ng/mL. Sample diluent alone was used as 0
(zero) standard. To start, 100 μL of prepared standards and
serum (no diluted) was added in duplicate to wells and incu-
bated at 24°C for 1 h. After washing six times with 1× Wash
Buffer, 100μL of diluted anti-Hsp60 goat polyclonal antibody
was added to each well and incubated at 24°C for 1 h. Then,
100 μL of diluted horse radish peroxidase-conjugate anti-goat
IgG was added to the plate and incubated at 24°C for 30 min.
After washing, 100 μL of 3,3′,5,5′-tetramethylbenzidine
substrate was added and incubated for 15 min in the
dark. Finally, 100 μL of Stop Solution was added and
absorbance was measured at 450 nm in a microplate
photometric reader (DV990BV4, GDV, Milan, Italy).
Sample concentration was calculated by interpolating
the sample concentrations in the standard curve. The
sensitivity of the Hsp60 (human), EIA was determined
to be 3.125 ng/mL. The intra-assay coefficient of variation of
Hsp60 (human) EIA was determined to be <10% and
the inter-assay coefficient of variation was determined to
also be <10%. Hsp60 (human). EIA is specific for
Hsp60 and the Hsp60 ELISA has been certified for
the detection of human Hsp60.
Tissue collection and processing
We collected, from the files of the Department of
Periodontology, Oral Surgery and Pathology, University of
Granada, Granada, Spain, formalin-fixed/paraffin-embedded
blocks of samples of periodontal mucosa randomly from 20
patients with mild periodontitis and 20 subjects with normal
oral mucosa. Immunostaining by avidin-biotin complex
method (LSAB2, DAKO, Carpinteria, CA, USA) was
performed on 4–5-μm sections from each case using
primary antibodies against Hsp60 (monoclonal mouse,
1:300, Sigma, Italy, cat. no. H4149). Appropriate posi-
tive controls, as well as non-immune serum for negative
controls, were run concurrently. Nuclear counterstaining
was done using hematoxylin (DAKO). Three indepen-
dent observers (FC, FR, and GB) examined the code-
marked specimens in blind mode, and performed a
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semiquantitative analysis to evaluate the percentage of
epithelial and stromal cells positive for Hsp60. All the
observations were made at a magnification of ×400 and
the means of triplicate counts were used for statistical
analyses.
Statistical analyses
Statistical analyses were performed using Statview® 5.0
(SAS Institute Inc., Cary, NC, USA). Univariate analyses
were performed using the non-parametric Mann-Whitney
test for numeric variables, while the differences in the prev-
alence for nominal variables were analyzed by the
McNemar test. Correlation analyses were performed using
the Spearman rank correlation method.
Results
Clinical and laboratory characteristics of patients and controls
are displayed in Table 1. No difference was found in the
prevalence of main risk factors for cardiovascular pathology,
such as hypertension, diabetes, and smoking addiction
between patients and controls. Patients had a clear evi-
dence of periodontal pathology compared to controls (as
measured by the Arbes index, p<0.0001) and gingival
inflammation (as measured by the gingival bleeding
index, p00.0007), while no difference was found between
the two groups in oral hygiene (as measured by the plaque
index). CRP levels were higher in patients than in controls but
the difference did not reach statistical significance. Similar
concentrations in plasma lipids were found in all inves-
tigated parameters in patients and controls, with the
only exception that patients had higher levels of small,
dense LDL (p00.0355). Serum Hsp60 concentrations were
considerably higher in patients than in controls (p<0.0001).
Spearman correlation analysis in patients with periodon-
titis showed that BMI was significantly correlated with all
lipid parameters (Table 2) and with CRP (all p<0.05).
Periodontal pathology positively correlated with levels of
total, LDL, and non-HDL-cholesterol, (all p<0.05), and
correlated inversely with HDL-cholesterol concentrations
(p<0.05). Serum Hsp60 levels inversely correlated with
HDL-cholesterol concentrations (p00.0039), and correlated
positively with levels of triglycerides (p<0.0001); this pos-
itive correlation of serumHsp60 levels was evenmore evident
with levels of small, dense LDL (r0+.925, p<0.0001, Fig. 1).
We have further analysed the data shown in the lower panel of
Fig. 1, excluding the data pertaining to the individual
exhibiting high Hsp60 and small, dense LDL values;
interestingly, we still found a significant correlation (p<0.05,
data not shown). Circulating Hsp60 levels also signifi-
cantly correlated with the degree of periodontal disease
(p00.0434). Spearman correlation analysis in the group
of controls did not reveal significant correlations (data
not shown).
Our immunohistochemical analyses of oral mucosa to
determine tissue levels of Hsp60 in patients with mild perio-
dontitis and matched controls did not reveal significant
differences between the two groups (Fig. 2). The levels of
Hsp60 were higher in epithelium than in lamina propria.
Likewise, Hsp60 levels tended to be higher (although
Table 1 Clinical and laboratory
characteristics of patients with
mild periodontitis and controls
Mean ± SD
ns not significant
Characteristic Controls, (n022) P value Patients (n022)
Age (years) 42±6 ns 42±5
Female gender, n (%) 13 (59) ns 13 (59)
Body-mass index (kg/m2) 26±3 ns 26±4
Periodontal pathology 0±0 <0.0001 13±12
Gingival inflammation 4±7 0.0007 26±19
Plaque index 9±6 ns 15±11
Hypertension, n (%) 1 (5) ns 1 (5)
Diabetes, n (%) 0 (0) ns 0 (0)
Smoking, n (%) 9 (41) ns 9 (41)
C-reactive protein (mg/L) 0.14±0.20 ns 0.27±0.39
Total cholesterol (mmol/L) 4.6±0.8 ns 4.8±0.8
Triglycerides (mmol/L) 1.0±0.5 ns 1.5±0.8
HDL-cholesterol (mmol/L) 1.7±0.4 ns 1.3±0.4
LDL-cholesterol (mmol/L) 2.6±0.7 ns 2.7±0.8
Non-HDL-cholesterol (mmol/L) 2.9±0.8 ns 3.2±0.9
Small dense LDL (0triglycerides/HDL-c ratio) 0.6±0.4 0.0355 1.3±0.5
Hsp60 (ng/mL) 0.4±0.3 <0.0001 14±21
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not statistically significant, p>0.05) in the periodontal
mucosa of healthy controls than in that of patients with
periodontitis.
Discussion
Dyslipidemia is common in subjects with periodontitis and
may be manifested as increased plasma LDL-cholesterol
and triglyceride levels as well as reduced HDL-cholesterol
concentrations (Cutler and Iacopino 2003). However, the
exact type and extent of atherogenic dyslipidemia in
periodontitis is still largely unknown and probably involves
alterations in lipoproteins, beyond those in plasma lipids
(Rufail et al 2005). In the present study, small alterations
in all plasma lipid parameters were found but they did not
reach statistical significance. In contrast, a significant dif-
ference was observed in the triglycerides/HDL-cholesterol
ratio, which is widely used as an indirect measure of small,
dense LDL (Décary et al. 2010). The quality, and not only
the quantity, of LDL seem to be associated with risk for
cardiovascular disease (Wierzbicki 2007). LDL comprises
multiple distinct subclasses that differ in size, density,
chemical composition, metabolic functions, and athero-
genicity (Rizzo and Berneis 2006). LDL particles are an
important predictor of cardiovascular pathological events
and progression of coronary artery disease, and the
predominance of small, dense LDL has been accepted
as an emerging risk factor for cardiovascular pathology
by the National Cholesterol Education Program Adult
Treatment Panel III. In addition, it has been shown in
recent years that there is a linear correlation between
the concentration of small, dense LDL particles and the
risk for the development of cardiovascular pathology
(Gardner et al. 1996; St Pierre et al. 2005). Therefore,
screening for the presence of small, dense LDL may
potentially identify subjects with higher risk for cardio-
vascular disease and help in establishing prevention
strategies. Patients with periodontitis have a higher risk
for cardiovascular pathology than the general population
(Scannapieco et al. 2003) and also have lipid and
Table 2 Spearman correlations between clinical and biochemical parameters in patients with periodontitis
Parameter Age BMI Periodontal pathology Plaque index Gingival bleeding index Hsp60
Total cholesterol 0.292 0.575** 0.432* −0.302 0.221 0.258
Triglycerides 0.245 0.408* 0.278 −0.213 −0.119 0.877***
HDL-cholesterol −0.295 −0.584** −0.485* 0.164 −0.185 −0.589**
LDL-cholesterol 0.257 0.550* 0.456* −0.223 0.279 0.030
Non-HDL-cholesterol 0.333 0.655*** 0.504* −0.302 0.240 0.233
Small, dense LDL 0.208 0.245 0.265 −0.216 −0.131 0.925***
C-reactive protein 0.005 0.536* −0.105 −0.144 0.124 −0.153
Hsp60 0.241 0.199 0.403* −0.027 −0.101 –
In bold the relationships that reached statistical significance
*p<0.05; **p<0.005; ***p≤0.0005
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Fig. 1 Correlations between Hsp60 levels in blood and clinical param-
eters. Spearman correlations between Hsp60 and degree of periodontal
pathology (upper panel) and between Hsp60 and small, dense LDL, as
indirectly assessed by the triglycerides/HDL-cholesterol ratio (bottom
panel), in patients with mild periodontitis
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lipoproteins alterations (Cutler and Iacopino 2003;
Rufail et al. 2005).
In the present study, patients with mild periodontitis did
not show alterations of statistical significance in plasma
lipids, including LDL-cholesterol but, interestingly, our
patients did show increased levels of small, dense LDL. In
brief, our patients had no quantitative abnormality in the
overall levels of plasma lipids but did show qualitative mod-
ifications, manifested as increased levels of small, dense LDL.
These findings are consistent with previous reports, showing
elevated levels of pro-atherogenic lipoproteins in periodontitis
(Rufail et al. 2005; Kallio et al. 2008; Bengtsson et al. 2008).
Our findings extend those previous observations to a popula-
tion of patients with periodontitis free of treatment prior and
during the study, namely patients that had not been modified
by medication. It has been hypothesized that oxidative stress
may be the link between atherosclerosis and periodontal
infection (Bullon et al. 2009); this view implies that
oxidative modifications of LDL represent an early stage
of atherosclerosis, and small, dense LDL are more sus-
ceptible to oxidation than larger, more buoyant subspe-
cies (Tribble et al. 2001). Recent evidence further
suggests that oxidative stress and atherogenic dyslipide-
mia have a synergistic impact on atherosclerosis and
cardiovascular diseases (reviewed in Rizzo et al. 2009).
We found that patients with periodontitis had higher con-
centrations of circulating Hsp60 than controls. This result
contrasts with that of previous works in which no difference
was found in the levels of circulating Hsp60 between patients
with periodontitis and controls (Buhlin et al. 2003; Shamaei-
Tousi et al. 2007). However, periodontitis patients had higher
intermediate levels of Hsp60 (Shamaei-Tousi et al. 2007). It
has to be emphasized that the methods used to measure
circulating Hsp60 in the two previous works just cited and
by us were not the same, which makes comparisons between
these studies if not impossible, at least of limited value.
Another difference between the aforementioned studies and
ours that impedes comparisons stems from the selection of
periodontitis cases examined, since our study is the only one
to focus on mild periodontitis.
Our immunohistochemical analysis not only aimed at
assessing levels of Hsp60 in the periodontal mucosa of
patients in comparison to that of the controls but also at
obtaining clues about the origins of the circulating
Fig. 2 Immunostaining for
Hsp60 in periodontal mucosa.
The non-parametric Mann–
Whitney test showed the
absence of significant differen-
ces in Hsp60 levels assessed
immunohistochemically
between patients with mild
periodontitis and healthy con-
trols in both epithelium and
lamina propria. The images are
representative of Hsp60 levels
in epithelium (a and b) and
lamina propria (c and d) in
healthy subjects (a and c) and
patients with mild periodontitis
(b and d). Bar: 50 microns. e
Histogram showing results of
semiquantitative evaluation of
Hsp60 immunostaining. Verti-
cal axis, semiquantitative scale
measuring amount of Hsp60
positivity in the tissue; n.s. not
significant
404 M. Rizzo et al.
Author's personal copy
chaperonin. Do pathological tissues produce elevated quan-
tities of Hsp60 in response to stressors, e.g., reactive oxygen
species or bacterial products, and the excess intracellular
chaperonin is secreted out of the cells and reaches the
circulating blood? The answer to this question seems to be
negative, at least in what pertains to the pathological peri-
odontal tissue we examined, since no difference was found
in the levels of Hsp60 between the mucosa of patients and
that of controls. Thus, the increased quantities of circulating
Hsp60 we detected in patients with mild periodontitis must
originate not in the pathological periodontal mucosa but
somewhere else.
We extended the previous observations mentioned
earlier by assessing the relationships between circulating
Hsp60 levels and risk factors for cardiovascular disease,
particularly atherogenic dyslipidemia. We found very
strong correlations between Hsp60 and small, dense
LDL and periodontal pathology. However, the parallel-
ism between levels of Hsp60, small dense LDL, and
periodontitis does not provide evidence for cause–effect
relationships between the parameters investigated. Could
it be that extracellular Hsp60 is involved in a cross talk
between lipoproteins and immune cells? Some recent
reports would tend to favour this view, for example: (a) the
lectin-like oxidized low-density lipoprotein receptor-1 of
macrophages was suggested to be a specific receptor for
Hsp60 that binds the chaperonin via its C terminus (Xie
et al. 2010); (b) immunization with a combination of
Hsp60 and apolipoprotein-B peptide antigen significantly
reduced early atherosclerotic lesions in a mouse model
(Lu et al. 2010); (c) it has been postulated that cario-
genic and periodontal pathogens can accelerate athero-
sclerosis in spontaneously hyperlipidemic mice by initiating
inflammation (Zhang et al. 2010); and (d) Hsp60 was found to
regulate some functions of oxidized LDL such as modulation
of F-actin capping proteins involved in actin polymerization
and macrophage motility (Dupont et al. 2008). These reports
tend to coincide with our observations in as much as that
circulating Hsp60 could play a role in chronic inflammation
and could become target for therapeutic measures aiming at
reducing the risk of atherogenic dyslipidemia and its compli-
cations. In this regard, our work shows that measuring the two
blood parameters, i.e., Hsp60 and small dense LDL, along
with periodontitis, is a promising strategy to predict risk for
cardiovascular pathology. The data encourage further research
on the possible role of Hsp60 and of small, dense LDL in the
pathogenesis of cardiovascular disease. The data also imply
that treatment of periodontitis (and by extension other mouth
and throat infections) may have beneficial effects in what
regards development of cardiovascular pathology.
Finally, although CRP levels were elevated in the patients
group, they remained well below the levels that are consid-
ered to be indicators of a risk of cardiovascular disease.
Also, we did not found any significant correlation between
CRP levels and periodontal pathology, plaque index, or
gingival bleeding index, suggesting a limited value of CRP
levels in the prediction of periodontitis in our patients. No
significant correlation was found between CRP and Hsp60
levels, either. In conclusion, we found that patients with
mild periodontitis undisturbed by any previous medication
show increased small, dense LDL and circulating Hsp60
concentrations as compared to matched controls. Correlation
analysis revealed a very strong relationship between these two
parameters, which were associated with periodontal patholo-
gy. Thus, our study opens the road for further investigation on
the value of elevated levels of circulating Hsp60 as predictor
of risk for cardiovascular disease when associated with dysli-
pidemia in periodontitis patients.
Acknowledgments This work has been supported by University of
Palermo (funds MR and FC) and IEMEST (Istituto Euro-Mediterraneo
di Scienza e Tecnologia; funds FC and AJLM).
References
Ainamo J, Bay I (1975) Problems and proposal for recording gingivitis
and placa. Dent J 25:229–235
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic
determination of total serum cholesterol. Clin Chem 20:470–475
Arbes SJ, Slade GD, Beck JD (1999) Association between extent of
periodontal attachment loss and self-reported history of heart
attack: an analysis of NHANES lll data. J Dent Res 78:1777–1782
Bengtsson T, Karlsson H, Gunnarsson P, Skoglund C, Elison C,
Leanderson P, Lindahl M (2008) The periodontal pathogen
Porphyromonas gingivalis cleaves apoB-100 and increases the
expression of apoM in LDL in whole blood leading to cell
proliferation. J Intern Med 263:558–571
Buhlin K, Gustafsson A, Pockley AG, Frostegård J, Klinge B (2003)
Risk factors for cardiovascular disease in patients with periodon-
titis. Eur Heart J 24:2099–2107
Buhlin K, Hultin M, Norderyd O, Persson L, Pockley AG, Rabe P,
Klinge B, Gustafsson A (2009) Risk factors for atherosclerosis in
cases with severe periodontitis. J Clin Periodontol 36:541–549
Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN,
Battino M (2009) Metabolic syndrome and periodontitis: is oxi-
dative stress a common link? J Dent Res 88:503–518
Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario
AJL (2009) Chlamydia trachomatis infection and anti-Hsp60
immunity: the two sides of the coin. PLoS Pathog 5:e1000552
Choi JI, Chung SW, Kang HS, Rhim BY, Park YM, Kim US, Kim SJ
(2004) Epitope mapping of Porphyromonas gingivalis heat-shock
protein and human heat-shock protein in human atherosclerosis. J
Dent Res 83:936–940
Choi J, Lee SY, Kim K, Choi BK (2011) Identification of immunore-
active epitopes of the Porphyromonas gingivalis heat shock pro-
tein in periodontitis and atherosclerosis. J Periodontal Res
46:240–245
Cueto A, Mesa F, Bravo M, Ocaña-Riola R (2005) Periodontitis as risk
factor for acute myocardial infarction. A case control study of
Spanish adults. J Periodontal Res 40:36–42
Cutler CW, Iacopino AM (2003) Periodontal disease: links with serum
lipid/triglyceride levels? Review and new data. J Int Acad
Periodontol 5:47–51
Hsp60 in patients with untreated mild periodontitis 405
Author's personal copy
D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield
J, Tsakos G (2008) Association of the metabolic syndrome with
severe periodontitis in a large U.S. population-based survey. J
Clin Endocrinol Metab 93:3989–3994
De Maio A (2011) Extracellular heat shock proteins, cellular export
vesicles, and the Stress Observation System: a form of commu-
nication during injury, infection, and cell damage. It is never
known how far a controversial finding will go! Dedicated to
Ferruccio Ritossa. Cell Stress Chaperones 16:235–249
Décary S, Dumont G, Lamarche B, Hogue JC, Tremblay AJ, Bergeron
J, Couture P (2010) Assessment of the validity of the frequently
used lipid indices for predicting LDL peak particle diameter in a
large cohort of 1955 normal and dyslipidemic subjects. Clin
Biochem 43:401–406
Dupont A, ChwastyniakM, BesemeO, Guihot AL, Drobecq H,Amouyel
P, Pinet F (2008) Application of saturation dye 2D-DIGE proteomics
to characterize proteins modulated by oxidized low density
lipoprotein treatment of human macrophages. J Proteome Res
7:3572–3582
Gardner CD, Fortmann SP, Krauss RM (1996) Association of
small low density lipoprotein particles with the incidence of
coronary artery disease in men and women. JAMA 276:875–
881
Gupta S, Knowlton AA (2007) HSP60 trafficking in adult cardiac
myocytes: role of the exosomal pathway. Am J Physiol Heart
Circ Physiol 292:H3052–H3056
Kallio KA, Buhlin K, Jauhiainen M, Keva R, Tuomainen AM, Klinge
B, Gustafsson A, Pussinen PJ (2008) Lipopolysaccharide associ-
ates with pro-atherogenic lipoproteins in periodontitis patients.
Innate Immun 14:247–253
Knoflach M, Bernhard D, Wick G (2005) Anti-HSP60 immunity is
already associated with atherosclerosis early in life. Ann N Y
Acad Sci 1051:323–331
Landis JR, Koch GG (1977) The measurement of observer agreement
for categorical data. Biometrics 33:159–174
Linhares IM, Witkin SS (2010) Immunopathogenic consequences
of Chlamydia trachomatis 60 kDa heat shock protein expres-
sion in the female reproductive tract. Cell Stress Chaperones
15:467–473
Lu X, Chen D, Endresz V, Xia M, Faludi I, Burian K, Szabo A, Csanadi
A, Miczak A, Gonczol E, Kakkar V (2010) Immunization with a
combination of ApoB and HSP60 epitopes significantly reduces
early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice.
Atherosclerosis 212:472–480
Macario AJL, Conway de Macario E (2005) Sick chaperones, cellular
stress, and disease. N Engl J Med 353:1489–1501
Macario AJL, Cappello F, Zummo G, Conway de Macario E (2010)
Chaperonopathies of senescence and the scrambling of interac-
tions between the chaperoning and the immune systems. Ann NY
Acad Sci 1197:85–93
Merendino AM, Bucchieri F, Campanella C, Marcianò V, Ribbene A,
David S, Zummo G, Burgio G, Corona DF, Conway de Macario
E, Macario AJL, Cappello F (2010) Hsp60 is actively secreted by
human tumor cells. PLoS One 5:e9247
Montagne P, Laroche P, Cuilliere ML, Varcin P, Duheille J (1992)
Microparticleenhanced nephelometric immunoassay for human
C- reactive protein. J Clin Lab Anal 1:24–29
Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P,
Wahlefeldet AW et al (1984) Reagent for the enzymatic determi-
nation of serum total triglycerides with improved lipolytic effi-
ciency. J Clin Chem Clin Biochem 22:165–174
Novo G, Cappello F, Rizzo M, Fazio G, Zambuto S, Tortorici E, Marino
Gammazza A, Corrao S, Zummo G, Conway de Macario E,
Macario AJL, Assennato P, Novo S, Li Volti G (2011) Hsp60 and
Heme Oxygenase-1 (Hsp32) in acute myocardial infarction. Transl
Res 157:285–292
O'Leary TJ, Drake RB, Naylor JE (1972) The plaque control record. J
Periodontol 43:38–40
Pfister G, Stroh CM, Perschinka H, Kind M, Knoflach M, Hinterdorfer
P, Wick G (2005) Detection of HSP60 on the membrane surface
of stressed human endothelial cells by atomic force and confocal
microscopy. J Cell Sci 118:1587–1594
Pockley AG, Multhoff G (2008) Cell stress proteins in extracellular
fluids: friend or foe? Novartis Found Symp 291:86–95, discussion
96-100, 137-140
Pockley AG, Bulmer J, Hanks BM, Wright BH (1999) Identification of
human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies
in the peripheral circulation of normal individuals. Cell Stress
Chaperones 4:29–35
Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegård J
(2000) Circulating heat shock protein 60 is associated with early
cardiovascular disease. Hypertension 36:303–307
Pockley AG, Muthana M, Calderwood SK (2008) The dual immuno-
regulatory roles of stress proteins. Trends Biochem Sci 33:71–79
Rizzo M, Berneis K (2006) Low-density-lipoproteins size and
cardiovascular risk assessment. QJM—Int J Med 99:1–14
Rizzo M, Kotur-Stevuljevic J, Berneis K, Spinas GA, Rini GB, Jelic-
Ivanovic Z, Spasojevic-Kalimanovska V, Vekic J (2009) Atherogenic
dyslipidemia and oxidative stress: a new look. Transl Res 153:217–
223
Rufail ML, Schenkein HA, Barbour SE, Tew JG, van Antwerpen R
(2005) Altered lipoprotein subclass distribution and PAF-AH
activity in subjects with generalized aggressive periodontitis. J
Lipid Res 46:2752–2760
Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, Koga T
(2004) The severity of periodontal disease is associated with the
development of glucose intolerance in non-diabetics: the
Hisayama study. J Dent Res 83:485–490
Scannapieco FA, Bush RB, Paju S (2003) Associations between peri-
odontal disease and risk for atherosclerosis, cardiovascular dis-
ease, and stroke. A systematic review. Ann Periodontol 8:38–53
Shamaei-Tousi A, D'Aiuto F, Nibali L, Steptoe A, Coates AR, Parkar
M, Donos N, Henderson B (2007) Differential regulation of
circulating levels of molecular chaperones in patients undergoing
treatment for periodontal disease. PLoS One 2:e1198
St Pierre AC, Cantin B, Dagenais GR, Mauriege P, Bernard PM,
Despres JP et al (2005) Low-density lipoprotein subfractions
and the long term risk of ischemic heart disease in men: 13-year
follow-up data from the Quebec Cardiovascular Study.
Arterioscler Thromb Vasc Biol 25:553–559
Tabeta K, Yamazaki K, Hotokezaka H, Yoshie H, Hara K (2000)
Elevated humoral immune response to heat shock protein 60
(hsp60) family in periodontitis patients. Clin Exp Immunol
120:285–293
Taylor BA, Tofler GH, Carey HM, Morel-Kopp MC, Philcox S, Carter
TR, Elliott MJ, Kull AD, Ward C, Schenck K (2006) Full-mouth
tooth extraction lowers systemic inflammatory and thrombotic
markers of cardiovascular risk. J Dent Res 85:74–78
Tonetti MS, D’Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan
J, Hingorani AD, Vallance P, Deanfield J (2007) Treatment of
periodontitis and endothelial function. N Engl J Med 356:911–
920
Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, Krauss
RM (2001) Enhanced oxidative susceptibility and reduced
antioxidant content of metabolic precursors of small dense
low-density lipoproteins. Am J Med 110:103–110
Warnick GR, Nguyen T, Albers JJ (1985) Comparison of improved
precipitation methods for quantification of high density lipopro-
tein cholesterol. Clin Chem 31:217–222
Wierzbicki AS (2007) Quality as well as quantity? Beyond low-density
lipoprotein-cholesterol – the role of particle size. Int J Clin Pract
61:1780–1782
406 M. Rizzo et al.
Author's personal copy
Williams RC (1990) Periodontal disease. N Engl J Med 322:373–382
Xie J, Zhu H, Guo L, Ruan Y, Wang L, Sun L, Zhou L, Wu W,
Yun X, Shen A, Gu J (2010) Lectin-like oxidized low-
density lipoprotein receptor-1 delivers heat shock protein
60-fused antigen into the MHC class I presentation pathway.
J Immunol 185:2306–2313
Yamazaki K, Ohsawa Y, Tabeta K, Ito H, Ueki K, Oda T, Yoshie H,
Seymour GJ (2002) Accumulation of human heat shock protein
60-reactive T cells in the gingival tissues of periodontitis patients.
Infect Immun 70:2492–2501
Yamazaki K, Ohsawa Y, Itoh H, Ueki K, Tabeta K, Oda T, Nakajima T,
Yoshie H, Saito S, Oguma F, Kodama M, Aizawa Y, Seymour GJ
(2004) T-cell clonality to Porphyromonas gingivalis and human
heat shock protein 60s in patients with atherosclerosis and perio-
dontitis. Oral Microbiol Immunol 19:160–167
Zhang X, He M, Cheng L, Chen Y, Zhou L, Zeng H, Pockley AG, Hu
FB, Wu T (2008) Elevated heat shock protein 60 levels are
associated with higher risk of coronary heart disease in Chinese.
Circulation 118:2687–2693
Zhang T, Kurita-Ochiai T, Hashizume T, Du Y, Oguchi S, Yamamoto
M (2010) Aggregatibacter actinomycetemcomitans accelerates
atherosclerosis with an increase in atherogenic factors in sponta-
neously hyperlipidemic mice. FEMS Immunol Med Microbiol
59:143–151
Hsp60 in patients with untreated mild periodontitis 407
Author's personal copy
